Brianna Wronko is the Founder & CEO of Group K Diagnostics (GKD), a biotechnology innovator aiming to overhaul the diagnostic process for both patient and caregiver, where she is responsible for the technological development and vision of the company. A bioengineer by training, Wronko has more than six years of experience in microfluidics and immunology research, startups, and the FDA approval process. Wronko sits on the Philadelphia Startup Leaders Board, was named a 2018 Philadelphia Business Journal Woman of Distinction and received recognition as the 2018 Spring PACT TiE Top Pitch Event Winner and the 2018 Stellar Startup Awards technology category winner. Wronko has spoken at the National Institute of Health, and is the recipient of other various grants and recognitions. She holds a BSE in Bioengineering from the University of Pennsylvania.